BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/26/2018 8:09:36 AM | Browse: 1357 | Download: 2714
 |
Received |
|
2017-09-29 00:19 |
|
Peer-Review Started |
|
2017-10-02 18:27 |
|
First Decision by Editorial Office Director |
|
2017-11-22 04:03 |
|
Return for Revision |
|
2017-11-27 11:19 |
|
Revised |
|
2017-12-04 06:38 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2017-12-08 10:48 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2017-12-13 22:15 |
|
Articles in Press |
|
2017-12-13 22:15 |
|
Edit the Manuscript by Language Editor |
|
2017-12-20 18:00 |
|
Typeset the Manuscript |
|
2018-01-18 15:25 |
|
Publish the Manuscript Online |
|
2018-01-26 08:09 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Efficacy of direct-acting antiviral treatment for chronic hepatitis C: A single hospital experience
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Rena Kaneko, Natsuko Nakazaki, Risa Omori, Yuichiro Yano, Masazumi Ogawa and Yuzuru Sato |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Japan Organization of Occupational Health and Safety |
359 |
|
| Corresponding Author |
Rena Kaneko, MD, Staff Physician, Department of Gastroenterology, Japan Organization of Occupational Health and Safety Kanto Rosai Hospital, Kizukisumiyoshi 1-1, Nakahara, Kawasaki 211-8510, Japan. rena332605@kantoh.johas.go.jp |
| Key Words |
Direct-acting antivirals; Resistance-associated substitutions; Hepatitis C; Sustained viral response |
| Core Tip |
Direct-acting antivirals (DAAs) have been approved for the treatment of hepatitis C virus (HCV) genotype 1 and 2 infection in Japan since 2011. In the new era of DAA therapy, predictors who fail to respond to DAA might be compromised by resistance-associated substitutions. There have been few reports of DCV/ASV(DAA) failure because DCV/ASV is limited in Japan. Therefore, it might be important to report these cases for future research and treatment of HCV. |
| Publish Date |
2018-01-26 08:09 |
| Citation |
Kaneko R, Nakazaki N, Omori R, Yano Y, Ogawa M, Sato Y. Efficacy of direct-acting antiviral treatment for chronic hepatitis C: A single hospital experience. World J Hepatol 2018; 10(1): 88-94 |
| URL |
http://www.wjgnet.com/1948-5182/full/v10/i1/88.htm |
| DOI |
http://dx.doi.org/10.4254/wjh.v10.i1.88 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
